Literature DB >> 15704381

Fatal toxicity of antidepressants in England and Wales, 1993-2002.

Oliver Morgan1, Clare Griffiths, Allan Baker, Azeem Majeed.   

Abstract

This article examines trends in drug poisoning deaths involving antidepressant drugs between 1993 and 2002 in England and Wales as a whole and focuses particularly on the relationship between antidepressant prescribing and deaths in England. Between 1993 and 2002, age-standardised mortality rates in England and Wales decreased from about 9 to 7 per million population for both males and females. However, unlike females, rates in males rose to a peak of 12 per million in 1997 before declining. During the study period, the number of prescription items for antidepressants increased two and a half fold, largely due to increased use of selective serotonin re-uptake inhibitors and other antidepressants. Overall, death rates in England, per million prescription items, declined over the study period, with reductions in the rates for Dothiepin, Amitriptyline and all tricyclic antidepressants. There was no change in the rate for selective serotonin re-uptake inhibitors while rates for other antidepressants increased. Despite these trends, through all the study period rates were highest for tricyclic antidepressants and lowest for selective serotonin re-uptake inhibitors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15704381

Source DB:  PubMed          Journal:  Health Stat Q        ISSN: 1465-1645


  9 in total

Review 1.  Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement.

Authors:  Hans-Jürgen Möller; David S Baldwin; Guy Goodwin; Siegfried Kasper; Ahmed Okasha; Dan J Stein; Rajiv Tandon; Marcio Versiani
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-08       Impact factor: 5.270

2.  Fatal venlafaxine poisonings are associated with a high prevalence of drug interactions.

Authors:  Terhi Launiainen; Ilpo Rasanen; Erkki Vuori; Ilkka Ojanperä
Journal:  Int J Legal Med       Date:  2010-04-30       Impact factor: 2.686

3.  A comparison of venlafaxine and SSRIs in deliberate self-poisoning.

Authors:  Agnes N Chan; Naren Gunja; Christopher J Ryan
Journal:  J Med Toxicol       Date:  2010-06

Review 4.  Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases.

Authors:  C Howell; A D Wilson; W S Waring
Journal:  Br J Clin Pharmacol       Date:  2007-02-12       Impact factor: 4.335

5.  Venlafaxine (Effexor): concerns about increased risk of fatal outcomes in overdose.

Authors:  Dorian Deshauer
Journal:  CMAJ       Date:  2006-12-13       Impact factor: 8.262

6.  Use of venlafaxine compared with other antidepressants and the risk of sudden cardiac death or near death: a nested case-control study.

Authors:  Carlos Martinez; Themistocles L Assimes; Daniel Mines; Sophie Dell'aniello; Samy Suissa
Journal:  BMJ       Date:  2010-02-05

Review 7.  Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the Literature.

Authors:  Silvia S Martins; Laura Sampson; Magdalena Cerdá; Sandro Galea
Journal:  Am J Public Health       Date:  2015-11       Impact factor: 9.308

8.  A review of the suitability of duloxetine and venlafaxine for use in patients with depression in primary care with a focus on cardiovascular safety, suicide and mortality due to antidepressant overdose.

Authors:  David Taylor; Alan Lenox-Smith; Andrew Bradley
Journal:  Ther Adv Psychopharmacol       Date:  2013-06

9.  Association between mortality from suicide in England and antidepressant prescribing: an ecological study.

Authors:  Oliver W C Morgan; Clare Griffiths; Azeem Majeed
Journal:  BMC Public Health       Date:  2004-12-21       Impact factor: 3.295

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.